XML 82 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (In shares) at Dec. 29, 2018   74,139,712,000      
Beginning balance at Dec. 29, 2018 $ 580,164 $ 74 $ 862,897 $ 780 $ (283,587)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (In shares)   301,497,000      
Issuance of common stock under the Employee Stock Purchase Plan 3,670 $ 0 3,670    
Issuance of common stock pursuant to exercise of options for cash (In shares)   19,207,000      
Issuance of common stock pursuant to exercise of options for cash 90   90    
Issuance of common stock pursuant to vesting of restricted stock units (In shares)   28,082,000      
Issuance of common stock pursuant to exercise of options (302)   (302)    
Stock-based compensation 5,262   5,262    
Other comprehensive loss (1,379)     (1,379)  
Net income 5,483       5,483
Ending balance (In shares) at Mar. 30, 2019   74,488,498,000      
Ending balance at Mar. 30, 2019 $ 592,988 $ 74 871,617 (599) (278,104)
Beginning balance (In shares) at Dec. 28, 2019 75,764,990 75,764,990,000      
Beginning balance at Dec. 28, 2019 $ 640,997 $ 76 885,821 (659) (244,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the Employee Stock Purchase Plan (In shares)   311,591,000      
Issuance of common stock under the Employee Stock Purchase Plan 4,066   4,066    
Issuance of common stock pursuant to exercise of options for cash (In shares)   55,769,000      
Issuance of common stock pursuant to exercise of options for cash 447 $ 1 446    
Issuance of common stock pursuant to vesting of restricted stock units (In shares)   25,901,000      
Issuance of common stock pursuant to exercise of options (385)   (385)    
Stock-based compensation 5,652   5,652    
Other comprehensive loss (250)     (250)  
Net income $ 15,890       15,890
Ending balance (In shares) at Mar. 28, 2020 76,158,251 76,158,251,000      
Ending balance at Mar. 28, 2020 $ 666,417 $ 77 $ 895,600 $ (909) $ (228,351)